A carregar...
Correcting oral contraceptive pharmacokinetic alterations due to obesity. A randomized controlled trial
OBJECTIVE: To determine if increasing the hormone dose or eliminating the hormone-free interval improves key pharmacokinetic (PK) alterations caused by obesity during oral contraceptive (OC) use. STUDY DESIGN: Obese (BMI ≥ 30 kg/m(2)), ovulatory, otherwise healthy, women received an OC containing 20...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4179976/ https://ncbi.nlm.nih.gov/pubmed/25070547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.contraception.2014.06.033 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|